This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yeung, R. S. Articles by Klein-Szanto, A. Search for Related Content PubMed PubMed Citation Articles by Yeung, R. S. Articles by Klein-Szanto, A.

American Journal of Pathology, Vol 151, 1477-1486, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis

RS Yeung, CD Katsetos and A Klein-Szanto
Division of Medical Sciences, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. ryeung@u.washington.edu

Tuberous sclerosis (TSC) is an autosomal dominant syndrome that is linked to two genetic loci: TSC1 (9q34) and TSC2 (16p13). Brain manifestations such as cortical tubers and subependymal hamartoma/giant cell astrocytomas are major causes of TSC-related morbidity. In this study, we describe the central nervous system involvement in a unique rodent model of tuberous sclerosis. The Eker rat carries a spontaneous germline mutation of the TSC2 gene and is predisposed to multiple neoplasia. In a series of 45 adult Eker carriers (TSC2 +/-), three types of focal intracranial lesions were found, of which the subependymal and subcortical hamartomas were most prevalent (65%). There exist remarkable phenotypic similarities between the Eker rat and human subependymal lesions. Our study indicates that the predominant cellular phenotype of the subependymal hamartomas is astroglial and suggests that the neuronal contribution within these lesions is, in part, the result of pre-existing myelinated axons. The hamartomas did not show evidence of loss of the wild-type TSC2 allele; it remains to be determined whether TSC2 inactivation is necessary for their pathogenesis. This genetically-defined rodent model may be useful in elucidating the molecular and developmental basis of the subependymal giant cell astrocytoma in humans.

This article has been cited by other articles:

				L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival J. Neurosci., May 23, 2007; 27(21): 5546 - 5558. [Abstract] [Full Text] [PDF]

				D. K. Scheidenhelm and D. H. Gutmann Mouse Models of Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 726 - 733. [Abstract] [PDF]

				M. R. Asato and A. Y. Hardan Topical Review : Neuropsychiatric Problems in Tuberous Sclerosis Complex J Child Neurol, April 1, 2004; 19(4): 241 - 249. [Abstract] [PDF]

				S. Jozwiak, D. Kwiatkowski, K. Kotulska, M. Larysz-Brysz, J. Lewin-Kowalik, W. Grajkowska, and M. Roszkowski Tuberin and Hamartin Expression Is Reduced in the Majority of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex Consistent With a Two-Hit Model of Pathogenesis J Child Neurol, February 1, 2004; 19(2): 102 - 106. [Abstract] [PDF]

				C. D. Katsetos, A. Legido, E. Perentes, and S. J. Mork Class III {beta}-Tubulin Isotype: A Key Cytoskeletal Protein at the Crossroads of Developmental Neurobiology and Tumor Neuropathology J Child Neurol, December 1, 2003; 18(12): 851 - 866. [Abstract] [PDF]

				S. Momose, T. Kobayashi, H. Mitani, M. Hirabayashi, K. Ito, M. Ueda, Y.-i. Nabeshima, and O. Hino Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system Hum. Mol. Genet., November 15, 2002; 11(24): 2997 - 3006. [Abstract] [Full Text] [PDF]

				K. S. Mcdorman and D. C. Wolf Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens Toxicol Pathol, October 1, 2002; 30(6): 675 - 680. [Abstract] [PDF]

				L. D. Morton, A. F. Youssef, E. Lloyd, A. L. Kiorpes, T. L. Goldsworthy, and F. L. Fort Evaluation of Carcinogenic Responses in the Eker Rat following Short-Term Exposure to Selected Nephrotoxins and Carcinogens Toxicol Pathol, August 1, 2002; 30(5): 559 - 564. [Abstract] [PDF]

				R. Kyin, Y. Hua, M. Baybis, B. Scheithauer, D. Kolson, E. Uhlmann, D. Gutmann, and P. B. Crino Differential Cellular Expression of Neurotrophins in Cortical Tubers of the Tuberous Sclerosis Complex Am. J. Pathol., October 1, 2001; 159(4): 1541 - 1554. [Abstract] [Full Text]

				S. Duniho, F. Y. Schulman, A. Morrison, H. Mena, and A. Koestner A Subependymal Giant Cell Astrocytoma in a Cat Vet. Pathol., May 1, 2000; 37(3): 275 - 278. [Abstract] [Full Text] [PDF]

				P. B. Crino and E. P. Henske New developments in the neurobiology of the tuberous sclerosis complex Neurology, October 22, 1999; 53(7): 1384 - 1384. [Abstract] [Full Text] [PDF]

				T. Kobayashi, O. Minowa, J. Kuno, H. Mitani, O. Hino, and T. Noda Renal Carcinogenesis, Hepatic Hemangiomatosis, and Embryonic Lethality Caused by a Germ-Line Tsc2 Mutation in Mice Cancer Res., March 1, 1999; 59(6): 1206 - 1211. [Abstract] [Full Text] [PDF]

				G. Rennebeck, E. V. Kleymenova, R. Anderson, R. S. Yeung, K. Artzt, and C. L. Walker Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development PNAS, December 22, 1998; 95(26): 15629 - 15634. [Abstract] [Full Text] [PDF]